Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Charterhouse Equity Partners was the private equity investment arm of Charterhouse Group, a New York-based firm founded in 1973. The firm specialized in middle-market buyouts and growth capital investments, with a strong historical focus on the healthcare services and medical technology sectors. Throughout its operation, Charterhouse employed a "build-up" strategy, acquiring platform companies and expanding them through strategic add-on acquisitions. Key healthcare investments included companies involved in nurse staffing, revenue cycle management, and specialized medical manufacturing. Notable portfolio companies in the healthcare space included Cross Country Healthcare and Chamberlin Edmonds. While a prominent player in the 1990s and early 2000s, the firm has since transitioned into a legacy phase and is no longer actively seeking new platform investments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Charterhouse Equity Partners.